Colorectal cancer (metastatic) - aflibercept: register to attend the appeal
The Institute has received one appeal against the Final Appraisal Determination on this technology. The Institute has arranged the hearing for the appeal received against the FAD for the above technology. The appeal panel will convene at 10am on 23 January 2014 at RIBA, 66 Portland Place, London W1B 1AD to hear oral representations from the appellants.
A hearing for one appeal against the final appraisal determination and guidance on Colorectal cancer - aflibercept [ID514] has been arranged.
The registration period for this appeal has now passed.
This page was last updated: 28 November 2013